HTG Molecular Diagnostics, Inc.
(NASDAQ : HTGM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 3.78%75.601.0%$2164.57m
AMGNAmgen, Inc. 4.33%206.861.3%$952.29m
REGNRegeneron Pharmaceuticals, Inc. 5.63%474.842.6%$819.23m
BIIBBiogen, Inc. 7.69%319.561.5%$766.58m
MRNAModerna, Inc. 1.23%30.420.0%$648.09m
VRTXVertex Pharmaceuticals, Inc. 6.40%231.151.9%$560.63m
ILMNIllumina, Inc. 1.84%273.993.5%$491.54m
ALXNAlexion Pharmaceuticals, Inc. 3.63%87.062.0%$275.41m
AAgilent Technologies, Inc. 2.05%72.181.6%$241.35m
EXASEXACT Sciences Corp. 0.94%58.4521.0%$207.42m
INCYIncyte Corp. 3.77%71.562.5%$173.86m
SGENSeattle Genetics, Inc. 4.47%114.156.1%$169.53m
BMRNBioMarin Pharmaceutical, Inc. 3.72%82.474.3%$166.32m
NVAXNovavax, Inc. 10.50%14.42114.7%$165.70m
CODXCo-Diagnostics, Inc. -10.38%8.200.0%$133.09m

Company Profile

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It offers instruments, reagents and services for molecular profiling applications. The firm serves biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.